Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Lung Neoplasms

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Lung Neoplasms in 2 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okamoto, M1
Kojima, H1
Saito, N1
Okabe, T1
Masuda, Y1
Furuya, T1
Nagano, T1
Klaeger, S1
Heinzlmeir, S1
Wilhelm, M1
Polzer, H1
Vick, B1
Koenig, PA1
Reinecke, M1
Ruprecht, B1
Petzoldt, S1
Meng, C1
Zecha, J1
Reiter, K1
Qiao, H1
Helm, D1
Koch, H1
Schoof, M1
Canevari, G1
Casale, E1
Depaolini, SR1
Feuchtinger, A1
Wu, Z1
Schmidt, T1
Rueckert, L1
Becker, W1
Huenges, J1
Garz, AK1
Gohlke, BO1
Zolg, DP1
Kayser, G1
Vooder, T1
Preissner, R1
Hahne, H1
Tõnisson, N1
Kramer, K1
Götze, K1
Bassermann, F1
Schlegl, J1
Ehrlich, HC1
Aiche, S1
Walch, A1
Greif, PA1
Schneider, S1
Felder, ER1
Ruland, J1
Médard, G1
Jeremias, I1
Spiekermann, K1
Kuster, B1

Other Studies

2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Lung Neoplasms

ArticleYear
Virtual screening and further development of novel ALK inhibitors.
    Bioorganic & medicinal chemistry, 2011, May-15, Volume: 19, Issue:10

    Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Drug Design; Humans; Lung Neoplasms; Mod

2011
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinas

2017